Lin Y, Liu Z, Dong M, Zhou W
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Dec 20;42(12):1907-1911. doi: 10.12122/j.issn.1673-4254.2022.12.22.
Although the portal vessels, liver sinusoids, and central vessels are known to contain microvessels with different structures and functions, their changes and roles in liver fibrogenesis have not been fully understood. Recent studies suggest that in mouse models of liver fibrogenesis, vascular changes can occur at a very early stage, and different liver vessels undergo different changes and play different roles, as shown by a decreased number of portal vessels, increased sinusoid capillarization and increased central vessels. The increase of portal vessels alleviates liver fibrosis, while the increase of central vessels and sinusoid capillarization aggravates liver fibrosis. A full understanding of the regulatory mechanisms of each of these vessels is vital for treatment of liver fibrosis. A combined regulation of different endothelial cell (EC) regulatory signaling pathways for vascular normalization may provide new strategies for liver fibrosis therapy. Further studies of the changes and functions of blood vessels in different liver diseases, liver development and regeneration may bring about important breakthroughs. This review summarizes the changes of 3 hepatic microvessels and their roles in liver fibrogenesis and propose the major directions of future studies in this field.
尽管已知门静脉、肝血窦和中央静脉含有结构和功能各异的微血管,但其在肝纤维化发生过程中的变化及作用尚未完全明确。近期研究表明,在肝纤维化小鼠模型中,血管变化可在极早期出现,不同的肝血管会发生不同变化并发挥不同作用,如门静脉数量减少、肝血窦毛细血管化增加以及中央静脉增多。门静脉增多可减轻肝纤维化,而中央静脉增多和肝血窦毛细血管化加剧则会加重肝纤维化。全面了解这些血管各自的调控机制对于肝纤维化治疗至关重要。对不同内皮细胞(EC)调控信号通路进行联合调控以实现血管正常化,可能为肝纤维化治疗提供新策略。进一步研究不同肝脏疾病、肝脏发育和再生过程中血管的变化及功能,可能会带来重要突破。本综述总结了三种肝微血管的变化及其在肝纤维化发生中的作用,并提出了该领域未来研究的主要方向。